Papanas N - Search Results

1

A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy.

Papanas N, Boulton AJ, Malik RA, Manes C, Schnell O, Spallone V, Tentolouris N, Tesfaye S, Valensi P, Ziegler D, Kempler P. Papanas N, et al. Diabet Med. 2013 May;30(5):525-34. doi: 10.1111/dme.12000. Diabet Med. 2013. PMID: 22924579 Review.

2

Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.

Papanas N, Papatheodorou K, Christakidis D, Papazoglou D, Giassakis G, Piperidou H, Monastiriotis C, Maltezos E. Papanas N, et al. Exp Clin Endocrinol Diabetes. 2005 Apr;113(4):195-8. doi: 10.1055/s-2005-837735. Exp Clin Endocrinol Diabetes. 2005. PMID: 15891953

3

Pseudoclaudication as a manifestation of diabetic neuropathy.

Papanas N, Edmonds M, Maltezos E. Papanas N, et al. Diabet Med. 2005 Nov;22(11):1608-10. doi: 10.1111/j.1464-5491.2005.01733.x. Diabet Med. 2005. PMID: 16241929

4

Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication.

Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E. Papanas N, et al. Exp Clin Endocrinol Diabetes. 2005 Dec;113(10):577-81. doi: 10.1055/s-2005-872912. Exp Clin Endocrinol Diabetes. 2005. PMID: 16320155 Clinical Trial.

5

The steel ball-bearing test: a new test for evaluating protective sensation in the diabetic foot.

Papanas N, Gries A, Maltezos E, Zick R. Papanas N, et al. Diabetologia. 2006 Apr;49(4):739-43. doi: 10.1007/s00125-005-0111-5. Epub 2006 Jan 20. Diabetologia. 2006. PMID: 16425034 Clinical Trial.

6

Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients.

Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Piperidou H, Maltezos E. Papanas N, et al. Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):58-61. doi: 10.1055/s-2007-955098. Exp Clin Endocrinol Diabetes. 2007. PMID: 17286238 Clinical Trial.

7

The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes.

Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E. Papanas N, et al. Diabetes Educ. 2007 Mar-Apr;33(2):257-8, 260, 262 passim. doi: 10.1177/0145721707299661. Diabetes Educ. 2007. PMID: 17426301

8

The diabetic foot in end stage renal disease.

Papanas N, Liakopoulos V, Maltezos E, Stefanidis I. Papanas N, et al. Ren Fail. 2007;29(5):519-28. doi: 10.1080/08860220701391662. Ren Fail. 2007. PMID: 17654312 Review.

9

The diabetic foot: established and emerging treatments.

Papanas N, Maltezos E. Papanas N, et al. Acta Clin Belg. 2007 Jul-Aug;62(4):230-8. doi: 10.1179/acb.2007.037. Acta Clin Belg. 2007. PMID: 17849694 Review.

10

Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.

Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Piperidou H, Maltezos E. Papanas N, et al. J Diabetes Complications. 2007 Nov-Dec;21(6):353-8. doi: 10.1016/j.jdiacomp.2006.08.003. J Diabetes Complications. 2007. PMID: 17967706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

503 results

Search Page